Navigation Links
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
Date:12/2/2007

NEW YORK and PITTSBURGH, Dec. 2 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and Mylan Inc. (NYSE: MYL) announced that Mylan has received an approvable letter from the U.S. Food and Drug Administration (FDA) in response to its New Drug Application (NDA) for nebivolol (proposed brand name Bystolic(TM)), a novel beta blocker under review for the treatment of hypertension.

In the approvable letter the FDA indicated that a recent inspection of a backup manufacturing facility in Belgium uncovered deficiencies and that final marketing approval for nebivolol would be contingent upon satisfactory resolution of these deficiencies. The approvable letter did not raise any questions related to safety or efficacy of nebivolol. At this time, the companies and the FDA have agreed upon product labeling text.

The companies anticipate an expeditious resolution to this issue, and Forest continues to plan for a January 2008 launch meeting for Bystolic.

Robert J. Coury, Vice Chairman and CEO for Mylan, stated, "Bystolic (nebivolol) is a valuable asset to our organization and will be to the medical community and the patient population it will serve."

Howard Solomon, Chairman and Chief Executive Officer of Forest, stated: "We remain very encouraged by the prospects for nebivolol and anticipate that, following FDA marketing approval, nebivolol will be an important and welcome new option for physicians. We will work expeditiously with the FDA to secure fina
'/>"/>

SOURCE Mylan Inc.; Forest Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
2. PowerBar Issues Open Call for 2008-2009 PowerBar Team Elite(TM) Athlete Sponsorship Program
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. American Red Cross Issues Blood Supply Alert
5. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
6. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
7. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
8. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
9. Dallas-Area Transplant Meeting Puts Spotlight on Key Issues
10. Elder Care Author Doctor Marion Launches Second National Tour to Raise Awareness About Aging & Elder Care Issues in America
11. California State PTA Issues Statement Regarding Presidents Veto of SCHIP Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Note: Dr. Julian is available for interviews ... , A phase III trial funded by the National ... carcinoma in situ (DCIS) now have an additional tool ... (NSABP B-35/NRG Oncology) looked at more than 3,000 DCIS ... with tamoxifen to those who completed five years of ...
(Date:6/1/2015)... More than 22 million children may miss out on milk’s ... they lose access to free or reduced-price meal programs. June ... companies are on a mission to bring more nutritious milk ... , In many cases, food insecure children depend on ... bulk of their daily nutrition. Although the National School Lunch ...
(Date:6/1/2015)... GA (PRWEB) June 01, 2015 June ... publisher of clinical journals in the areas of hospital ... to announce that it has expanded upon its partnership ... journal, Hospital Medicine Practice, in a mobile application ... and tablets. , “We are very excited about ...
(Date:6/1/2015)... GA. (PRWEB) June 01, 2015 Hexagon ... Online, which is a new cloud-based subscription service that ... and GIS software. , Both ERDAS IMAGINE ... access through Producer Online, which offers a subscription model ... “Today’s organizations need to be able to quickly and ...
(Date:6/1/2015)... 2015 A University of Texas ... signaling proteins that activate protein degradation, which helps ... 1 , The study published April 3rd ... Spraque-Dawley rats 2-3 months of age who performed ... given either whey protein (.4g/kg), low-dose Sustamine (.1g/kg), ...
Breaking Medicine News(10 mins):Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 3
... The Australian Medical Students’ Association (AMSA) is hosting the ... Students’ Associations (IFMSA).// ,Medical students from 70 ... for the commencement of the biannual conference. AMSA is ... last year in Santiago, Chile. ,Representing ...
... Perkins is on top of the world, literally. ... mountaineering feats, as she scaled another mountain peak,// this time in ... She led her team up one of several unnamed peaks in ... more than 650 miles west of Buenos Aires. ,Perkins ...
... in protest of a new smoking ban to hit the nation-and ... July first onwards, actors will be allowed to light up only ... ,This, believes Equity, the Actors union, is unfair. Says spokes ... performers should be able to rehearse properly with any prop, including ...
... stress can damage a child's brain, say researchers at ... //Children's Hospital. The researchers found that children with post-traumatic ... cortisol were likely to experience a decrease in the ... in memory processing and emotion. ,Although similar ...
... More things are wrought by prayers than the world dreams of ... ,"It's a known fact that golf maestro Tiger Woods meditates and ... marketing at Le Meriden Gokarna Forest Golf Resort and Spa, Kathmandu's ... very much a mind game." ,So to help golfers ...
... a provisional safety rating until their safety and ... experts have said in the latest Medical Journal ... and some other prescription medicines, which were withdrawn ... reliance on pre-marketing trials and voluntary adverse reaction ...
Cached Medicine News:Health News:Severe PTSD Damages Children's Brains: Study 2Health News:Severe PTSD Damages Children's Brains: Study 3Health News:Nepal to Introduce Art of Living for Golfers 2Health News:Time to Overhaul Australia's Medicines Safety Surveillance System 2
(Date:6/1/2015)... 2015 NSHOA Cancer Center and Heron ... positive, top-line results from its recently completed Phase ... safety of the Company,s 5-HT 3 receptor ... extended release) as part of a three-drug regimen ... receptor antagonist fosaprepitant and the IV corticosteroid dexamethasone ...
(Date:6/1/2015)... , June 1, 2015   OTC ... Open, Transparent and Connected financial marketplaces for 10,000 ... a San Diego -based biopharmaceutical ... on OTCQB®, America,s only public venture market for ... - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO "We,re ...
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, ... ("DelMar" and the "Company"), a biopharmaceutical company focused on ... drug indications, announced that it will be hosting a ... 1, 2015, at 5:30 p.m. CDT (6:30 p.m. EDT). ... I/II study of VAL-083 (dianhydrogalactitol) in patients ...
Breaking Medicine Technology:New cancer therapy study results - MAGIC Trial 2OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme 2DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme 3DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme 4
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...
... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
Medicine Products: